To report any concerns or inaccuracies, please contact us at editor@investorplace.com. The post AGEN Stock Earnings: Agenus Misses EPS, Misses Revenue for Q1 2024 appeared first on InvestorPlace.

Baird raised the price target for the Agenus Inc (NASDAQ:AGEN) stock to “an Outperform”. The rating was released on June 06, 2023, according to finviz. We previously noted in another research note ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Investors considering a purchase of Agenus Inc (Symbol: AGEN) stock, but tentative about paying the going market price of $7.08/share, might benefit from considering selling puts among the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

(RTTNews) - Agenus Inc. (AGEN) stock is falling over 14 percent on Friday morning after the announcement of updated data from its phase 1 clinical trial of BOT/BAL combination therapy in patients ...

Build your portfolio and react to the markets in real time. Compete against your friends or coworkers to earn your spot at the top of the leaderboards. If you are a teacher, professor or ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Small-Cap Cancer Drug Developer Agenus' Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom The latest Phase 1 trial results of Agenus' botensilimab and balstilimab (BOT ...

People walk on an overpass past office towers in the Lujiazui financial district of Shanghai, China October 17, 2022. REUTERS/Aly Song/File Photo Emboldened by China's latest measures and pledges ...